FDA’s Center for Biologics Evaluation and Research will host a 30-minute webinar on the agency’s efforts to ensure the safety of vaccines. There will be an opportunity to ask questions following the presentation on July 13, 2010, at 2:00 p.m. EDT. More information is available here: https://www.drugs.com/fda-consumer/july-13-webinar-fda-s-safety-monitoring-of-approved-vaccines-147.html See also, timely FDA Consumer Updates here: https://www.drugs.com/fda-consumer
FDA Announces Collaboration With Drugs.com
A new partnership forged by the two entities provides consumers with a joint resource on Drugs.com that features FDA Consumer Update articles, videos, and slide-shows. It will also bring FDA health information to the Drugs.com’s mobile phone platform at drugs.mobi. “The partnership with Drugs.com means that reliable, useful, and timely health information will be available […]
Drugs.com receives another Webby nomination
We are extremely proud to announce that Drugs.com has been nominated for a second prestigious Webby Award. To be judged among the Internet’s top 5 health web sites is indeed an honor. The Webby People’s Voice Awards is also one of the few major awards that invite the public to participate by allowing you to […]
Drugs.com Refutes Erroneous Claims
This week in Washington, D.C. saw the public hearings on promotion of FDA-regulated medical products using the internet and social media tools. Drugs.com got a mention and a reference or two by one of the speakers. People heard, wrote, tweeted, blogged, reported and within minutes the quote had gone viral on the internet. The problem […]
We’ve been Nominated for a Webby Award!
Drugs.com is one of only five websites that have been nominated for the 2009 Webby Awards in the Best Health Website category. We are both honored and humbled to receive this nomination. Update: The ballot has now closed. A big thanks to those who voted for us.
Follow us on twitter
We now have our own twitter page for anybody who would like a quick and easy way to follow what is happening at Drugs.com. Check it out at twitter.com/Drugscom.